Vestal Point Capital, LP Ultragenyx Pharmaceutical Inc. Transaction History
Vestal Point Capital, LP
- $1.34 Trillion
- Q2 2024
A detailed history of Vestal Point Capital, LP transactions in Ultragenyx Pharmaceutical Inc. stock. As of the latest transaction made, Vestal Point Capital, LP holds 1,800,000 shares of RARE stock, worth $91.9 Million. This represents 5.52% of its overall portfolio holdings.
Number of Shares
1,800,000
Previous 110,000
1536.36%
Holding current value
$91.9 Million
Previous $5.14 Billion
1340.45%
% of portfolio
5.52%
Previous 0.42%
Shares
2 transactions
Others Institutions Holding RARE
# of Institutions
292Shares Held
88.4MCall Options Held
505KPut Options Held
198K-
Vanguard Group Inc Valley Forge, PA9.78MShares$499 Million0.01% of portfolio
-
Black Rock Inc. New York, NY5.6MShares$286 Million0.01% of portfolio
-
Sands Capital Management, LLC Arlington, VA5.35MShares$273 Million0.68% of portfolio
-
Wellington Management Group LLP Boston, MA4.56MShares$233 Million0.03% of portfolio
-
Rtw Investments, LP New York, NY3.26MShares$166 Million2.24% of portfolio
About Ultragenyx Pharmaceutical Inc.
- Ticker RARE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 70,036,896
- Market Cap $3.58B
- Description
- Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in North America, Europe, and internationally. Its biologic products include Crysvita (burosumab), an antibody targeting fibroblast...